In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...

“Even with all of the advances in diabetes technology, insulin therapy is still overwhelming and complex,” said Mike Mason, who heads Lilly’s connected care and insulins programme. Bundling ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

A completely new way of treating type 1 diabetes is being tested at Uppsala University Hospital. Patients are being offered ...

Eli Lilly's LLY short percent of float has risen 5.88% since its last report. The company recently reported that it has 6.10 million shares sold short, which is 0.72% of all regular shares that are ...

TD Cowen analyst Michael Nedelcovych has maintained their bullish stance on NVO stock, giving a Buy rating on January 13.Stay Ahead of the ...

Background The study of endogenous insulin secretion may provide relevant insight into the comparison of the natural history of adult onset latent autoimmune diabetes (LADA) with types 1 and 2 ...

A bill to lower the price of insulin drugs and supplies for more North Dakotans attracted passionate discussion during a hearing before the House Government and Veteran Affairs Committee. House Bill ...

David M. Nathan, MD; Mayer B. Davidson, MD; Ralph A. DeFronzo, MD; Robert J. Heine, MD, PHD, FRCP; Robert R. Henry, MD; Richard Pratley, MD; Bernard Zinman, MD The ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.